Table 1 Clinical characteristics of CRC patients with nonresectable liver metastases.
Patient | Age (years)/sex | Response | Survival duration (months) | TS expression* before treatment | TS expression* after treatment |
|---|---|---|---|---|---|
1 | 50/F | PD | 4 | 4 | 11 |
2 | 70/M | PD | 20 | 4 | 12 |
3 | 69/F | PD | 17 | 5 | 21 |
4 | 61/M | PD | 20 | 12 | 34 |
5 | 44/F | PD | 27 | 15 | 47 |
6 | 53/M | PD | 5 | 10 | 9 |
7 | 56/F | PD | 9 | 23 | ND |
8 | 58/M | PD | 7 | 14 | ND |
9 | 60/F | PD | 13 | 15 | ND |
10 | 52/M | SD | 11 | 9 | 14 |
11 | 79/M | SD | 25 | 17 | ND |
12 | 49/F | SD | 34 | 32 | ND |
13 | 63/M | SD | 8 | 20 | ND |
14 | 56/F | SD | 5 | 19 | ND |
15 | 51/F | PR | 17 | 20 | ND |
16 | 65/M | PR | 21 | 6 | ND |
17 | 55/M | PR | 17 | 8 | ND |
18 | 70/M | PR | 28 | 15 | ND |
19 | 73/F | PR | 81 | 8 | ND |
20 | 65/M | CR | 47 | 8 | ND |